Verifying…
Home / Drug A–Z / Super Apeti Plus Tablets

Super Apeti Plus Tablets

NAFDAC Reg. No. B4-1654 · Drug

Registered with NAFDAC — registration activeAs of 6 November 2026 · synced automatically from official sources.
Product
Super Apeti Plus Tablets
NAFDAC number
B4-1654
Active ingredient
Cyproheptadine Hydrochloride; Vit A; Vit D; Vit B1; Vit B2; Vit B12; Nicotinamide; Dexpanthenol
Strength
2 mg; 1600 IU; 200 IU; 2 mg; 2 mg; 1 mcg; 15 mg; 5 mg
Form
Tablet
Manufacturer
Not listed
Applicant (holder)
Shalina Healthcare Nigeria Limited
Approved
10 Nov 2020
Status
Inactive View on NAFDAC ↗
Registration valid to
9 Nov 2025
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Super Apeti Plus Tablets is on the NAFDAC register with an active registration (B4-1654). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Super Apeti Plus Tablets is used for

From the official U.S. FDA label for cyproheptadine hydrochloride, the active ingredient registered with NAFDAC.

What it is used for

Perennial and seasonal allergic rhinitis, Vasomotor rhinitis, Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma. Cold urticaria. Dermatographism. As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.

Possible side effects

Adverse reactions which have been reported with the use of antihistamines are as follows: Central Nervous System: Sedation and sleepiness (often transient), dizziness, disturbed coordination, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, paresthesias, neuritis, convulsions, euphoria, hallucinations, hysteria, faintness. Integumentary: Allergic manifestation of rash and edema, excessive perspiration, urticaria, photosensitivity. Special Senses: Acute labyrinthitis, blurred vision, diplopia, vertigo, tinnitus. Cardiovascular: Hypotension, palpitation, tachycardia, extrasystoles, anaphylactic shock. …

Do not use if

Newborn or Premature Infants: This drug should not be used in newborn or premature infants. Nursing Mothers: Because of the higher risk of antihistamines for infants generally, and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. Other Conditions: Hypersensitivity to cyproheptadine and other drugs of similar chemical structure. Monoamine oxidase inhibitor therapy (see DRUG INTERACTIONS ). Angle-closure glaucoma. Stenosing peptic ulcer. …

Warnings

Children - Overdosage of antihistamines, particularly in infants and children, may produce hallucinations, central nervous system depression, convulsions, and death. Antihistamines may diminish mental alertness conversely particularly in the young child they may occasionally produce excitation. CNS Depressants - Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents. Activities Requiring Mental Alertness - Patients should be warned about engaging in activities requiring mental alertness and motor coordination, such as driving a car or operating machinery. …

Pregnancy & breastfeeding

PREGNANCY Pregnancy Category B: Reproduction studies have been performed in rabbits, mice, and rats at oral or subcutaneous doses up to 32 times the maximum recommended human oral dose and have revealed no evidence of impaired fertility or harm to the fetus due to cyproheptadine. Cyproheptadine has been shown to be fetotoxic in rats when given by intraperitoneal injection in doses four times the maximum recommended human oral dose. …

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

NAFDAC recall & alert notices

Public Alert 002/2022 – Alert on Recall of Lidocaine HCI Topical Solution USP, 4% by Teligent Pharma, Due to Super Potency10 Feb 2022 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control (NAFDAC)  has received information from US FDA that Teligent Pharma, Inc. is voluntarily recalling two lots of Lidocaine HCl Topical Solution USP 4%, 50ml in a screw cap glass bottle. The product is being recalled because the firms testing has found it …Public Alert No. 003/2021 – Recall of Hygiaflore Psyllium Bio Transit Capsule by Super Diet Laboratories24 Mar 2021 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control has received information that the Directorate-General for Competition, Consumer Affairs and Fraud Control of France has warned the French public about the recall of Hygiaflore Psyllium Bio Transit Capsule, a plant based food supplement by Super Diet due…Recall Of DDAVP® Nasal Spray 10mcg/0.1ml, Desmopressin Acetate Nasal Spray 10mcg/0.1ml, STIMATE® Nasal Spray 1.5mg/ml Due To Superpotency1 Oct 2020 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control has received information from the US FDA that Ferring Pharmaceuticals US is voluntarily recalling all lots of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE® Nasal Spray 1.5 mg/mL to the consumer level. These…

Notices list affected brands and batch numbers — compare them with your pack. Enter your batch number above to check it automatically.

Check your pack of Super Apeti Plus Tablets

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Super Apeti Plus Tablets

What is in Super Apeti Plus Tablets?

Super Apeti Plus Tablets contains Cyproheptadine Hydrochloride; Vit A; Vit D; Vit B1; Vit B2; Vit B12; Nicotinamide; Dexpanthenol (2 mg; 1600 IU; 200 IU; 2 mg; 2 mg; 1 mcg; 15 mg; 5 mg), as tablet, according to its NAFDAC registration record.

Is Super Apeti Plus Tablets registered with NAFDAC?

Yes. Super Apeti Plus Tablets is listed on the NAFDAC register under registration number B4-1654, and its registration is active as of 6 November 2026.

Has Super Apeti Plus Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Super Apeti Plus Tablets in our automatically synced alert list.

How can I check that my pack of Super Apeti Plus Tablets is genuine?

Run a free authenticity scan with the NAFDAC number B4-1654, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Super Apeti Plus Tablets used for?

Perennial and seasonal allergic rhinitis, Vasomotor rhinitis, Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma. Cold urticaria. Dermatographism. As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute man (Summarised from the official U.S. FDA label for cyproheptadine hydrochloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Super Apeti Plus Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.